A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis
Authors:
Open Access
- 4 January 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 9, 696
Abstract
Clinicopathological characteristics alone are not enough to predict the survival of patients with cervical squamous cell carcinoma (CESC) due to clinical heterogeneity. In recent years, many genes and non-coding RNAs have been shown to be oncogenes or tumor-suppressors in CESC cells. This study aimed to develop a comprehensive transcriptomic signature for CESC patient prognosis. Univariate, multivariate, and Least Absolute Shrinkage and Selection Operator penalized Cox regression were used to identify prognostic signatures for CESC patients from transcriptomic data of The Cancer Genome Atlas. A normalized prognostic index (NPI) was formulated as a synthetical index for CESC prognosis. Time-dependent receiver operating characteristic curve analysis was used to compare prognostic signatures. A prognostic transcriptomic signature was identified, including 1 microRNA, 1 long non-coding RNA, and 6 messenger RNAs. Decreased survival was associated with CESC patients being in the high-risk group stratified by NPI. The NPI was an independent predictor for CESC patient prognosis and it outperformed the known clinicopathological characteristics, microRNA-only signature, gene-only signature, and previously identified microRNA and gene signatures. Function and pathway enrichment analysis revealed that the identified prognostic RNAs were mainly involved in angiogenesis. In conclusion, we proposed a transcriptomic signature for CESC prognosis and it may be useful for effective clinical risk management of CESC patients. Moreover, RNAs in the transcriptomic signature provided clues for downstream experimental validation and mechanism exploration.Keywords
This publication has 50 references indexed in Scilit:
- Tyrosylprotein Sulfotransferase-1 and Tyrosine Sulfation of Chemokine Receptor 4 Are Induced by Epstein-Barr Virus Encoded Latent Membrane Protein 1 and Associated with the Metastatic Potential of Human Nasopharyngeal CarcinomaPLOS ONE, 2013
- CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cellsin vitroLeukemia & Lymphoma, 2012
- Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cellsThe Journal of Pathology, 2011
- PHD2 in tumour angiogenesisBritish Journal of Cancer, 2010
- A MicroRNA Expression Signature for Cervical Cancer PrognosisCancer Research, 2010
- Sequential Tyrosine Sulfation of CXCR4 by Tyrosylprotein SulfotransferasesBiochemistry, 2008
- A unified approach to false discovery rate estimationBMC Bioinformatics, 2008
- RUNX3 Inhibits the Expression of Vascular Endothelial Growth Factor and Reduces the Angiogenesis, Growth, and Metastasis of Human Gastric CancerClinical Cancer Research, 2006
- Proportional Hazards Tests and Diagnostics Based on Weighted ResidualsBiometrika, 1994
- Estimating the Dimension of a ModelThe Annals of Statistics, 1978